Joined February 2012
- Tweets 106
- Following 53
- Followers 1,002
- Likes 24
18 Photos and videos
Michael Frumovitz retweeted
20 Apr 2024
The call for proposals is just days away! Mucinous Ovarian Cancer Coalition/MOCC invites researchers to submit abstracts for requests of up to $50,000. Find the full guidelines here: hope4moc.org/researching/
@Frumovitz @katiekurnit @JennyMueller_ @SGO_org
3
4
1,840
23 Jan 2024
We now have FOUR potential clinical trials open at @MDAndersonNews for patients with small cell/large cell/neuroendocrine cervical cancer. Both targeted and immunotherapies. Excited to offer so many opportunities to patients with this rare cancer @SARCC @LaurenByersMD
3
8
75
4,965
Michael Frumovitz retweeted
22 Sep 2023
Clinicopathologic characteristics, oncologic outcomes & prognostic factors in #neuroendocrine #CervicalCarcinoma #NECTURstudy
@ajhingran @MDAndersonNews @frumovitz
bit.ly/3tbUAZS
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @OncoAlert
19
40
6,216
Michael Frumovitz retweeted
12 May 2023
Honored to receive the Felix Rutledge Society travel award and excited to be presenting my research at this year’s annual @WAGO_org meeting!
I am so grateful for my Hopkins family and amazing mentors 😊
@HopkinsGynOnc
@MDAndersonNews
3
2
48
6,146
Michael Frumovitz retweeted
11 May 2023
“This is likely the most comprehensive book for these rare gynecological cancers.” -©Doody’s Review Service, 2023. Read full review: spkl.io/601545B1D
@frumovitz, @leitaomd, @NancyDEditor
ALT Cover of Diagnosis and Treatment of Rare Gynecologic Cancers, 1st Edition.
1
11
43
6,183
Michael Frumovitz retweeted
10 May 2023
The Mucinous Ovarian Cancer Coalition (MOCC) is pleased to announce "Rhonda's Award 2023" is now open. We will accept submissions for grants up to $50,000. Focus must be on #MucinousOvarianCancer Find more details here: hope4moc.org/researching/
4
7
1,141
Michael Frumovitz retweeted
18 Apr 2023
“Both the physical textbook and the ebook achieve this goal and provide guidance from workup to primary treatment to recurrence and surveillance strategies.” -©Doody’s Review Service, 2023. Read full review: spkl.io/60174dIgV
@frumovitz @leitaomd @NancyDEditor
ALT Cover of Diagnosis and Treatment of Rare Gynecologic Cancers, 1st Edition.
1
5
24
6,245
Michael Frumovitz retweeted
7 Apr 2023
Diagnosis and Treatment of Rare Gynecologic Cancers a.co/d/66lOUp0 #Amazon
7
23
2,827
Michael Frumovitz retweeted
24 Mar 2023
Patient Experience rounds are back @MDAndersonNews with @Frumovitz CPXO. Outstanding work going on in Head and Neck Center improving responsiveness and informing about wait times. Their scores reflect their hard work! All domains reached goal this quarter! #ServiceExcellence
2
25
1,543
1 Oct 2022
So excited to be at the @Allyson4Rare gala in support of young people with cancer. So appreciative of their amazing support of our #NECC research. @MDAndersonNews @SCCCLCCCSisters
4
2
55
Michael Frumovitz retweeted
27 Sep 2022
The Mucinous Ovarian Cancer Coalition (MOCC) is pleased to announce Dr. Kylie Gorringe as the recipient of Rhonda's Award. Find all of the details about this annual grant and Dr. Gorringe here: hope4moc.org/mocc-funds-rese…
@Frumovitz @JennyMueller_ @katiekurnit
2
11
Michael Frumovitz retweeted
5 Jul 2022
The deadline to apply for up to $50,000 to fund research on mucinous ovarian cancer is July 14th. Find details about Rhonda's Award here: hope4moc.org/researching/
@Frumovitz @JennyMueller_ @katiekurnit
4
3
2 Jun 2022
$50K Rhonda’s Award to support research in mucinous ovarian cancer now being offered by the Mucinous Ovarian Cancer Coalition/MOCC. Details/deadlines here: hope4moc.org/researching/ Great opportunity for research in this #raretumor @SGO_org @ESGO_society @IGCSociety @ShelleyMLM
16
29
Michael Frumovitz retweeted
24 May 2022
Excited to share a new research award for mucinous ovarian cancer! Application now open, deadline on 6/2. Can’t wait to make some much needed progress for this #raretumor @ShelleyMLM @Frumovitz @JennyMueller_ hope4moc.org/researching/
6
20
Michael Frumovitz retweeted
12 May 2022
We are the Mucinous Ovarian Cancer Coalition. Launched by my late sister in September of 2020. In addition to financial supportnd opinions, and resources, we fund research grants. RFPs for Rhonda’s Award begins on June 2nd for grants up to $50k. hope4moc.org #gyncsm
2
13
37
4 Mar 2022
Our trial with immunotherapy AK104 (cadonilimab) for women with neuroendocrine cervix cancer at @MDAndersonNews opened just this week! We already have 1 enrolled and 2 in screening. Trials for #raretumors are possible! @SGO_org @NANETS1 @SCCCLCCCSisters @ShannonWestin @karenluMD
3
13
81
24 Feb 2022
Stay tuned! Our trial with AK104 (cadonilimab), a bispecific PD1/CTLA4 antibody, for women with neuroendocrine cervical cancer should open next week! So close!! @SCCCLCCCSisters @SGO_org @NANETS1
4
24
Michael Frumovitz retweeted
17 Feb 2022
Health care providers, join us tonight’s Physician Advisory Council meeting, where we will be joined by MD Anderson President Dr. Peter WT Pisters. The virtual event is from 6-7 p.m. CST. Register here: bit.ly/3I2lfLi @PPisters #EndCancer
4
5
10 Jan 2022
Excited to announce our clinical trial with surgery and #HIPEC for recurrent mucinous ovarian cancer is now open at @MDAndersonNews. Will also open at MSKCC later this year with our colleagues @zivanovicmd and @JennyMueller_. @ShelleyMLM @katiekurnit @AnilSoodMD
5
16
100
17 Dec 2021
Our lab at @MDAndersonNews draws blood from > 15,000 patients/week and always provides outstanding #serviceexcellence to every single one of our cancer patients. Congratulations for their outstanding patient scores for #patientexperience. @BethGarciaMDA
1
16